Improving treatment options for sarcoma patients through clinical trials and advocacy.
Core C: Clinical Trials and Patient Advocacy
This study is working to improve treatments for sarcoma, a rare cancer that can affect anyone, by finding better ways to help both kids and adults get the right care they need.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10848819 on NIH RePORTER |
What this research studies
This research focuses on enhancing treatment strategies for sarcoma, a rare type of cancer that affects individuals of all ages. It aims to address the unique challenges of conducting clinical trials for various sarcoma subtypes, which require tailored therapeutic approaches. The project will support the translational and clinical efforts of the Memorial Sloan Kettering Cancer Center's programs for both adult and pediatric sarcoma patients, ensuring that innovative therapies are accessible across different age groups. By fostering collaboration and advocacy, the research seeks to improve patient outcomes and advance the understanding of sarcoma.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with sarcoma, regardless of age, who are seeking new treatment options.
Not a fit: Patients with non-sarcoma cancers or those who do not meet the specific criteria for sarcoma treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for sarcoma, significantly improving survival rates and quality of life for patients.
How similar studies have performed: Previous research has shown promise in improving treatment outcomes for sarcoma through tailored clinical trials, indicating that this approach has potential for success.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Tap, William D. — Sloan-Kettering Inst Can Research
- Study coordinator: Tap, William D.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.